Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Cash from Restructuring (2019 - 2020)

Dolby Laboratories (DLB) has disclosed Cash from Restructuring for 2 consecutive years, with $8.1 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Cash from Restructuring rose 1571.81% year-over-year to $8.1 million, compared with a TTM value of $9.3 million through Dec 2020, down 72.5%, and an annual FY2020 reading of $1.6 million, down 95.07% over the prior year.
  • Cash from Restructuring was $8.1 million for Q4 2020 at Dolby Laboratories, up from $199000.0 in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $27.5 million in Q2 2019 and bottomed at $116000.0 in Q1 2020.